Sp746
LOCAL GASTROINTESTINAL REACTIONS TO FOOD IN DGBI
Date
May 8, 2023
Explore related products in the following collection:
Society: AGA
A session focusing on recent advances in our understanding of the complex pathophysiology of disorders of gut-brain interaction (DGBI). This session will enable attendees to appreciate the interaction between different pathophysiological factors in symptom generation in DGBI, and use this knowledge to explain the underlying mechanisms to their DGBI patients.
A session focusing on recent advances in our understanding of the complex pathophysiology of disorders of gut-brain interaction (DGBI). This session will enable attendees to appreciate the interaction between different pathophysiological factors in symptom generation in DGBI, and use this knowledge to explain the underlying mechanisms to their DGBI patients.
Presenter
Tracks
Related Products
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
IS IT DYSPEPSIA OR GASTROPARESIS
Back by popular demand, the experts will share and debate the evidence and their approaches to chronic pain, defecatory disorders, dyspepsia. and gastroparesis…
PLACEHOLDER
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
FAILURES AND SUCCESSES AMONG BIOIMARKERS FOR FUNCTIONAL DYSPEPSIA
DDW attendees will have the opportunity to learn about recent developments in biomarker-discovery for FGID/DGBI and Neurogastroenterology…
